The role of myocardial innervation imaging in different clinical scenarios: an expert document of the European Association of Cardiovascular Imaging and Cardiovascular Committee of the European Association of Nuclear Medicine.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 14 12 2020
accepted: 08 01 2021
pubmed: 2 2 2021
medline: 6 8 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Cardiac sympathetic activity plays a key role in supporting cardiac function in both health and disease conditions, and nuclear cardiac imaging has always represented the only way for the non-invasive evaluation of the functional integrity of cardiac sympathetic terminals, mainly through the use of radiopharmaceuticals that are analogues of norepinephrine and, in particular, with the use of 123I-mIBG imaging. This technique demonstrates the presence of cardiac sympathetic dysfunction in different cardiac pathologies, linking the severity of sympathetic nervous system impairment to adverse patient's prognosis. This article will outline the state-of-the-art of cardiac 123I-mIBG imaging and define the value and clinical applications in the different fields of cardiovascular diseases.

Identifiants

pubmed: 33523108
pii: 6125312
doi: 10.1093/ehjci/jeab007
doi:

Substances chimiques

Radiopharmaceuticals 0
3-Iodobenzylguanidine 35MRW7B4AD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-490

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Alessia Gimelli (A)

Department of Imaging, Fondazione Toscana/CNR Gabriele Monasterio1, via Moruzzi n.1, Pisa 56124, Italy.

Riccardo Liga (R)

Cardiac-Thoracic-Vascular Department, Università di Pisa, Pisa, Italy.

Denis Agostini (D)

Department of Nuclear Medicine, University Hospital of Normandy, CHU Cote de Nacre, Caen, France.

Frank M Bengel (FM)

Department of Nuclear Medicine, Hannover Medical School (MHH), Hannover, Germany.

Sabine Ernst (S)

Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College, London, UK.

Fabien Hyafil (F)

Department of Nuclear Medicine, European Hospital Georges-Pompidou, DMU IMAGINA, Assistance Publique-Hôpitaux de Paris, University of Paris, Paris, France.

Antti Saraste (A)

Turku PET Centre, University of Turku, Turku, Finland.
Heart Center, Turku University Hospital, Turku, Finland.

Arthur J H A Scholte (AJHA)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Hein J Verberne (HJ)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Derk O Verschure (DO)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Cardiology, Zaans Medical Center, Zaandam, the Netherlands.

Riemer H J A Slart (RHJA)

Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Centre, University Medical Center Groningen, Groningen, The Netherlands.
Faculty of Science and Technology, Biomedical Photonic Imaging, University of Twente, Enschede, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH